level-one heading

Writers
Data Analysts
Consultants
Product Developers
Researchers
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 45 /hr
Hire Sagar V.
United Kingdom
USD 45 /hr

Freelance Cell Biology Consultant | Expert in Stem Cell Behaviour

Profile Summary
Subject Matter Expertise
Services
Writing Non-Medical Regulatory Writing, Technical Writing, Audio Transcription, General Proofreading & Editing
Research Fact Checking, Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review
Consulting Operations Consulting, Scientific and Technical Consulting, Regulatory Consulting
Product Development Quality Assurance & Control (QA/QC)
Work Experience

ShiftBioscience Ltd.

March 2025 - Present

Lead Scientist

UncommonBio Ltd.

July 2022 - January 2025

Research Associate

Cambridge Stem Cell Institute

December 2019 - June 2022

Post Doctoral Fellow

Indian Institute of Science

August 2019 - December 2019

Lecturer

Ramnarain Ruia College

July 2011 - June 2012

Education

PhD Biotechnology (Ovarian Cancer Biology Group)

National Centre For Cell Science

August 2012 - Present

MSc. Biotechnology (Department of Biotechnology)

Savitribai Phule Pune University

July 2009 - June 2011

BSc. Biotechnology (Biotechnology)

Ramnarain Ruia College

July 2006 - May 2009

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Madhuri H. More, Sagar S. Varankar, Rutika R. Naik, Rahul D. Dhake, Pritha Ray, Rahul M. Bankar, Avinash M. Mali, Ayalur Raghu Subbalakshmi, Priyanka Chakraborty, Mohit Kumar Jolly, et al. (2024). A Multistep Tumor Growth Model of High-Grade Serous Ovarian Carcinoma Identifies Hypoxia-Associated Signatures . Cells Tissues Organs.
Teresa Brevini, Mailis Maes, Gwilym J. Webb, Binu V. John, Claudia D. Fuchs, Gustav Buescher, Lu Wang, Chelsea Griffiths, Marnie L. Brown, William E. Scott, et al. (2023). FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 . Nature.
Cell geometry distinguishes migration‐associated heterogeneity in two‐dimensional systems <head> <META HTTP-EQUIV="Refresh" CONTENT="0;URL=/servlet/useragent"> </head> . Computational and Systems Oncology.
Sagar S Varankar, Erik C Cardoso, Joo-Hyeon Lee (2022). Ex situ-armus: experimental models for combating respiratory dysfunction . Current Opinion in Genetics &amp; Development.
A monoclonal antibody against annexin A2 targets stem and progenitor cell fractions in tumors @article{2022, doi = {10.1016/j.tranon.2021.101257}, url = {https://doi.org/10.1016%2Fj.tranon.2021.101257}, year = 2022, month = {jan}, publisher = {Elsevier {BV}}, volume = {15}, number = {1}, pages = {101257}, author = {Rajkumar S. Kalra and Gaurav S. Soman and Pradeep B. Parab and Avinash M. Mali and Sagar S. Varankar and Rutika R. Naik and Swapnil C. Kamble and Jaspreet K. Dhanjal and Sharmila A. Bapat}, title = {A monoclonal antibody against annexin A2 targets stem and progenitor cell fractions in tumors}} . Translational Oncology.
Sagar S. Varankar, Sharmila A. Bapat (2019). Uncoupling Traditional Functionalities of Metastasis: The Parting of Ways with Real-Time Assays . Journal of Clinical Medicine.
(2019). Uncoupling Traditional Functionalities of Metastasis: The Parting of Ways with Real-Time Assays . Journal of Clinical Medicine.
(2019). Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines . Carcinogenesis.
(2018). Migratory Metrics of Wound Healing: A Quantification Approach for in vitro Scratch Assays . Frontiers in Oncology.
OTHER
Sagar Varankar, Teresa Brevini, Mailis Maes, Gwilym J. Webb, William T. H. Gelson, Sally Forrest, Petra Mlcochova, Scott Dillon, Mahnaz Darvish-Damavandi, Victoria L. Mulcahy, et al.(2021). FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome . Cold Spring Harbor Laboratory